共 50 条
- [21] Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters Annals of Surgical Oncology, 2016, 23 : 99 - 105
- [22] Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis Annals of Surgical Oncology, 2015, 22 : 2656 - 2662
- [23] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 259 - 261
- [25] Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: History, clinical applications, and implementation EJSO, 2021, 47 (01): : 65 - 74
- [26] Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer JOURNAL OF BUON, 2018, 23 (02): : 482 - 487
- [27] Peritoneal carcinomatosis and gastric cancer. Role of surgery and HIPEC ONKOLOGE, 2016, 22 (06): : 413 - 418
- [28] Re-do cytoreductive surgery for peritoneal surface malignancy: Is it worthwhile? SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2020, 18 (05): : 287 - 294